organization · Reporting owner
M&G Alternatives Investment Management Ltd
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Barinthus Biotherapeutics plc.VACC · Entity 9597 | 10% owner | September 30, 2022 | October 04, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Barinthus Biotherapeutics plc.
Report date September 30, 2022 · Filed October 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | IndirectPlease see footnote | 0 |
Reported balance
After 2022-09-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-09-30 · Other · Disposed 4,108,752 · Balance 0 F1: Each share representing one ordinary share. F2: The reported securities were held directly by Prudential Credit Opportunities SCSP, advised by M&G Alternatives Investment Management Limited. The reported securities may be deemed beneficially owned for the purposes of Section 13(d) of the Securities Exchange Act 1934 by M&G Alternatives Investment Management Limited as investment manager to these funds. The Reporting Person disclaims beneficial ownership of the securities for purposes of Rule 16a-1(a)(2) and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share representing one ordinary share.
F2: The reported securities were held directly by Prudential Credit Opportunities SCSP, advised by M&G Alternatives Investment Management Limited. The reported securities may be deemed beneficially owned for the purposes of Section 13(d) of the Securities Exchange Act 1934 by M&G Alternatives Investment Management Limited as investment manager to these funds. The Reporting Person disclaims beneficial ownership of the securities for purposes of Rule 16a-1(a)(2) and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2022 Filed Oct 4, 2022 17:03 UTC | Barinthus Biotherapeutics plc. VACC · Entity 9597 | OtherAmerican Depositary Shares | 4,108,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-018101 · doc1.xml · nonDerivative · entry 1 M&G Alternatives Investment Management Ltd · CIK 0001891922 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote Disclosed balance after: 0 F1 · security: Each share representing one ordinary share. F2 · ownership.nature: The reported securities were held directly by Prudential Credit Opportunities SCSP, advised by M&G Alternatives Investment Management Limited. The reported securities may be deemed beneficially owned for the purposes of Section 13(d) of the Securities Exchange Act 1934 by M&G Alternatives Investment Management Limited as investment manager to these funds. The Reporting Person disclaims beneficial ownership of the securities for purposes of Rule 16a-1(a)(2) and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.